Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Identify Biomarker Modulation by a Cyclooxygenase-2 (COX-2) Inhibitor in Breast Tissue of Premenopausal Women at High Risk for Estrogen Receptor Negative (ERN) Breast Cancer

NCT00056082 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT00056082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00056082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Identify Biomarker Modulation by a Cyclooxygenase-2 (COX-2) Inhibitor in Breast Tissue of Premenopausal Women at High Risk for Estrogen Receptor Negative (ERN) Breast Cancer
Lead sponsor
University of Kansas Medical Center
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2003
Completion date
July 31, 2013
Enrollment
110 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer